Actively Recruiting

Age: 18Years +
All Genders
NCT05523245

Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI

Led by Sixth Affiliated Hospital, Sun Yat-sen University · Updated on 2026-04-23

1700

Participants Needed

4

Research Sites

283 weeks

Total Duration

On this page

Sponsors

S

Sixth Affiliated Hospital, Sun Yat-sen University

Lead Sponsor

F

Fifth Affiliated Hospital, Sun Yat-Sen University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Establish a deep learning model based on multi-parameter magnetic resonance imaging to predict the efficacy of neoadjuvant therapy for locally advanced rectal cancer.This study intends to combine DCE with conventional MRI images for DL, establish a multi-parameter MRI model for predicting the efficacy of CRT, and compare it with the DL and non-artificial quantitative MRI diagnostic model constructed by conventional MRI to evaluate the role of DL in MRI predicting CRT. And this study also tries to build a DL platform to assess the efficacy of LARC neoadjuvant radiotherapy and chemotherapy, accurately assess patients' complete respose (pCR) after CRT, and provide an important basis for guiding clinical decision-making.

CONDITIONS

Official Title

Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinical suspicion or colonoscopic pathology of rectal cancer
  • Age over 18 years
  • Informed consent and signed informed consent form
Not Eligible

You will not qualify if you...

  • Poor magnetic resonance image quality, such as severe artifacts
  • Previous treatment for rectal cancer
  • History or combination of other malignant tumours
  • Not Locally Advanced Rectal Cancer (LARC)
  • Not received neoadjuvant therapy or not completed neoadjuvant therapy
  • No surgery
  • Time interval between MRI and surgery was more than 2 weeks
  • Patients were lost to follow-up and voluntarily withdrew from the study due to adverse reactions or other reasons

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Sixth Affiliated Hospital, Sun Yat-sen University

Guangzhou, Guangdong, China

Actively Recruiting

2

The First Affiliated Hospital of Jinan University

Guangzhou, Guangdong, China

Not Yet Recruiting

3

The Second Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China

Not Yet Recruiting

4

Fifth Affiliated Hospital, Sun Yat-sen University

Zhuhai, Guangdong, China

Not Yet Recruiting

Loading map...

Research Team

X

Xiaochun Meng

CONTACT

P

Peiyi Xie

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI | DecenTrialz